Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q71678289)
Watch
English
Long-term efficacy and safety of terazosin in patients with benign prostatic hyperplasia. Terazosin Research Group
scientific article published on 01 March 1995
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7533452
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7533452%20AND%20SRC:MED&resulttype=core&format=json
retrieved
20 October 2019
title
Long-term efficacy and safety of terazosin in patients with benign prostatic hyperplasia. Terazosin Research Group
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7533452
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7533452%20AND%20SRC:MED&resulttype=core&format=json
retrieved
20 October 2019
author name string
H Lepor
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7533452
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7533452%20AND%20SRC:MED&resulttype=core&format=json
retrieved
20 October 2019
language of work or name
English
0 references
publication date
1 March 1995
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7533452
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7533452%20AND%20SRC:MED&resulttype=core&format=json
retrieved
20 October 2019
published in
Urology
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7533452
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7533452%20AND%20SRC:MED&resulttype=core&format=json
retrieved
20 October 2019
volume
45
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7533452
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7533452%20AND%20SRC:MED&resulttype=core&format=json
retrieved
20 October 2019
issue
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7533452
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7533452%20AND%20SRC:MED&resulttype=core&format=json
retrieved
20 October 2019
page(s)
406-413
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7533452
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7533452%20AND%20SRC:MED&resulttype=core&format=json
retrieved
20 October 2019
cites work
Light Microscopic Stereological Analysis of the Normal Human Prostate and of Benign Prostatic Hyperplasia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980008-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Quantifying the smooth muscle content of the prostate using double-immunoenzymatic staining and color assisted image analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980008-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The alpha adrenergic binding properties of terazosin in the human prostate adenoma and canine brain
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980008-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The response to alpha blockade in benign prostatic hyperplasia is related to the percent area density of prostate smooth muscle
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980008-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A Placebo-controlled Double-blind Study of the Effect of Phenoxybenzamine in Benign Prostatic Obstruction
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980008-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bladder Outflow Obstruction Treated with Phenoxybenzamine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980008-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of Prazosin in Patients with Benign Prostatic Obstruction
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980008-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prazosin in the Treatment of Prostatic Obstruction A Placebo-controlled Study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980008-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A Dose Titration Study Evaluating Terazosin, a Selective, Once-a-Day α 1-Blocker for the Treatment of Symptomatic Benign Prostatic Hyperplasia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980008-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of once-A-day terazosin in benign prostatic hyperplasia: A randomized, double-blind placebo-controlled clinical trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980008-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The efficacy and safety of terazosin for the treatment of symptomatic BPH
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980008-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The safety, efficacy and compliance of terazosin therapy for benign prostatic hyperplasia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980008-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Use of terazosin in the medical treatment of benign prostatic hyperplasia: experience in Italy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980008-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A Randomized, Placebo-Controlled Multicenter Study of the Efficacy and Safety of Terazosin in the Treatment of Benign Prostatic Hyperplasia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980008-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Terazosin in the treatment of benign prostatic hyperplasia: a multicentre, placebo-controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980008-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The management of symptomatic benign prostatic hyperplasia with the once-daily alpha 1 blocker, terazosin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980008-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of terazosin in patients with benign prostatic hyperplasia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980008-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0090-4295(99)80008-9
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7533452
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7533452%20AND%20SRC:MED&resulttype=core&format=json
retrieved
20 October 2019
PubMed publication ID
7533452
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7533452
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7533452%20AND%20SRC:MED&resulttype=core&format=json
retrieved
20 October 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
